For HealthTech product and engineering teams

Add document intelligence without hiding the evidence.

KamiBridge designs source-linked extraction, coding-support and document QA workflows that can fit an existing product. Evaluate the input, output, review controls and deployment boundary before committing to a broad build.

The operating problem

A model demo is not yet a dependable product workflow.

Medical documents arrive as inconsistent PDFs, scans, exports and structured records.
Model output is difficult to debug when it cannot point back to the exact source context.
A useful product needs explicit exceptions, reviewer actions and audit-ready state—not only an API response.
Integration, hosting and retention constraints often determine feasibility before model quality does.

Controlled evaluation

A bounded product slice with explicit acceptance criteria.

01

Define the contract

Agree one input, one output, evidence coordinates and responsibility boundaries.

02

Build the slice

Create the smallest working flow with normalization, rules and review states.

03

Evaluate failures

Inspect missing evidence, ambiguity, exceptions and integration friction.

04

Plan the handoff

Document APIs, deployment options, monitoring and the next production decision.

What you receive

Evidence for a go—or no-go decision.

A working evidence-linked workflow for one representative input.

Review-ready JSON, CSV or a defined FHIR resource when appropriate.

Exception states, reviewer actions and failure-case findings.

Architecture and deployment recommendations for the existing product.

A good fit

You already own the surrounding product and user workflow.

You need medical-document context as well as implementation capacity.

You can evaluate a narrow capability before a larger roadmap commitment.

Not the right fit

You only need general staff augmentation with no defined workflow.

You require unsupported compliance or performance claims.

You want a generic chatbot or model wrapper without source traceability.

Start without patient data.

The first review and demonstration use synthetic information. Data flow, access, hosting, retention and human responsibility must be agreed before any real-data evaluation.